Publication:
Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV.

dc.contributor.authorMacías, Juan
dc.contributor.authorFernández-Fuertes, Marta
dc.contributor.authorOliver, Noemí
dc.contributor.authorCorma-Gómez, Anaïs
dc.contributor.authorReal, Luis M
dc.contributor.authorPineda, Juan A
dc.date.accessioned2023-05-03T14:52:45Z
dc.date.available2023-05-03T14:52:45Z
dc.date.issued2022-02-10
dc.identifier.doi10.1016/j.cmi.2022.01.028
dc.identifier.essn1469-0691
dc.identifier.pmcPMC8828385
dc.identifier.pmid35150883
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828385/pdf
dc.identifier.unpaywallURLhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X22000520/pdf
dc.identifier.urihttp://hdl.handle.net/10668/22126
dc.issue.number5
dc.journal.titleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
dc.journal.titleabbreviationClin Microbiol Infect
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationAGS - Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.page.number755-756
dc.pubmedtypeLetter
dc.rights.accessRightsopen access
dc.subject.meshAntibodies, Viral
dc.subject.meshCOVID-19
dc.subject.meshHIV Infections
dc.subject.meshHumans
dc.subject.meshNeutralization Tests
dc.subject.meshProbability
dc.titleLower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number28
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8828385.pdf
Size:
250.24 KB
Format:
Adobe Portable Document Format